SV

Srinu Vurlapu .

Regulatory Compliance Manager at Amgen India

Srinu Vurlapu is a seasoned professional in regulatory and quality assurance with extensive experience in the pharmaceutical and clinical research sectors. Currently serving as a Regulatory Compliance Manager at Amgen India since May 2025, Srinu has previously held significant roles such as Operational Compliance Specialist II and Operational Compliance Specialist at Imaging Endpoints, a prominent US-based clinical research organization in oncology, from January 2022 to May 2025. A tenure at Sanofi from August 2017 to January 2022 included positions as Assistant Manager QA and Senior Executive QA, while earlier experiences involved working as Senior Executive QA at Pfizer and as QA Junior Executive at Kemwell Biopharma. Srinu began a career in quality assurance as a QA Chemist at Beloorbayir Biotech Ltd. Educational qualifications include a Master of Pharmacy in Pharmaceutical Technology from Sri Sai Aditya Institute of Pharmaceutical Science & Research, completed in 2012.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Amgen India

3 followers

Amgen India’s technology and innovation site in Hyderabad is a critical component of Amgen's global strategy to accelerate its digital transformation, innovation efforts and further support Amgen’s mission of serving more patients. With an initial focus on building and scaling advanced technology solutions and digital capabilities, Amgen India will enhance efficiencies across the enterprise, supporting key areas such as AI, data science, and life sciences. If you are keen to shape the future of biotechnology and are interested in working with Amgen, visit our careers page https://careers.amgen.com/en/india 🔗Social media guidelines - https://wwwext.amgen.com/community-guidelines 🔗Privacy Statement - https://www.amgen.co.in/privacy-statement


Industries

Headquarters

Hyderabad, India

Employees

1,001-5,000

Links